Mutant IDH1 and IDH2 generate 2-hydroxyglutarate, disrupt TET2 function, enforce DNA hypermethylation, and impair differentiation in acute myeloid leukemia, showing that metabolic alterations can be causal rather than merely correlative [5]. Here, IDH2 is linked to acute myeloid leukemia.